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We have xpressed receptor-binding domams of human g,-macrogiobuhn and rat a~-maeroglobuhn m E~cherteh[a colt Expresmon levels of both 
recombmants were qutte lugh, but the human one was in.~oluble, probably forming inclusion bodies. The rat domain, which laths the human 
dl~u!fide, wa~ prodaegd ma soluble form and readily purified by two simple chromatographic steps Purified recombinant ra at-macroslobnlin 
leceptor-binding domain was fully functional inbinding to the ¢~-macroglobulin receptor n human fibroblasts. Tics 142 residue domain should 
serve a~ an excellent template for analyzing the structural requiicment~ for cc-macroglobulin receptor ligation and dissecting the vat icd biological 
funct~on~ r ttlun8 from such Iigauon 
~-Mac~oglobuhn: Protein expression; L~poprotem receptor 
1. INTRODUCTION 
=-Macroglobulins (~Ms), such as human ~2-mac- 
roglobulin (~2M) and rat ~-maeroglobulin (0~M), 
probably constitute a general proteinase clearance sys. 
tern and backup to the more specific proteivase inhib- 
itors present in mammals [1]. Related to the ~tMs, al- 
though with distinct functions, are the complement 
components, C3 and C4. Although they probably di- 
verged uring early chordate volution [2], certain prop- 
erties re~ eal that C3, C4 and the 0tMs descended from 
a common ancestor. These properties include primary 
sequence homology, activation by endopeptiAases in a 
region equidistant frona the terminals of the precursor 
protein chains, and the presence of an intra-¢hain/3- 
cysteinyl-7-glutamyl thiol ester about one third of the 
distance from the C-terminus (reviewed by %ttrup- 
Jensen [31). In modern vertebrates, C3 and C4 partici- 
pate in proinflammatory and cytolytie reactions in re- 
sponse to infectious agents [4]. 
Following reaction with proteinases~ the complement 
components and most aMs undergo a conformational 
change that results in exposure of a receptor recognition 
site. Receptor ligation allows C3- and C4-coated parti- 
cles to bind blood cells to aid in immune complex clear- 
anee and promote phagocytosis. The receptor that rec- 
ognizes the proteinase-inhibitory ctM~ has a much 
broader cell-type distribution (for review see Pizzo [5]). 
Although initially thought only to be responsible for 
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removal of aM-protemase comple×es, hgation of the 
receptor may also influence cellular functions [6-8]. 
The human aM receptor has been cloned ~nd se- 
quenced [9,10]0 and is identical to one previously re- 
ported as the low density lipoproteln receptor-related 
protein (LRP). The LRP receptor is responsible for 
binding apolipoprotein E-enriched fl-migzating very 
low density lipoproteins [11], although this receptor 
may not be the primary one for ,uptake of fl-migrating 
very low density lipoproteins in vivo [12], Very recently, 
the ~M/LRP receptor has also been shown to bind 
Pseudomouas exotoxin A [13] and tissue plasminogen 
activator, either alone or via its complex witn a specific 
tissue inhibitor [14015]. It thus seems that this single 
receptor is capable of binding and internalizing several 
distinct ligands, none of which appear to show signifi- 
cant sequence homology, and most of which probably 
b~nd to different sites on the receptor. 
ctMs derived from various mammals show compar:t- 
ble binding affinities for mouse and human receptors, 
suggesting that the specificity of the interaction ishighly 
conserved. A 20-30 kDa C-terminal fragment derived 
from the 180 kDa parent chain of ~Ms contains most, 
if not all, of the information required for binding to the 
cellular eceptor [16-19]. Although C3 and C4 are ho- 
mologous to ~xMs, flley utilize different regions of their 
polypeptide chains for receptor binding. Moreover, 
complement receptors 2 and 3 recognize primary se- 
quence pitopes whereas binding of 0~Ms to their recep- 
tor is dependent on the correct folding of the ligand 
/3,4]. Consequently, peptide-based strategies that have 
been employed to characterize the complement recep- 
tor-binding epitopes are unlikely to succeed in defining 
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the aM-receptor binding site. To characterize the region 
of aM-~ responsible for recognizing the receptor we are 
expressing small regions of the parent molecules in 
forms that preserve binding activity. These can serve as 
templates for mutagenesis trategies and allow dissec- 
tion of the biological effects of cxM receptor ligation. 
In the present study, we report the cloning and ex- 
pression of the C-terminal receptor binding domain 
from rat ~x~M. Our use of rat a~M, rather than another 
0~M, is based on the following two principles. Firstly, 
this is the only known cxM devoid of the 1,329-1,444 
disulfide [20] (human a~M numbering system). Sec- 
ondly, a fragment of  40 kDa isolated from rat c~lM~ 
which contains the C-terminal receptor binding site, had 
previously been shown to regain activity following dial- 
ysis from 6 M guanidinium chloride [19]. Consequently, 
folding should be spontaneous and not be dependent on 
disulfide formation. 
2. EXPERIMENTAL 
2.1 Matermts 
E~cher/chla col/ TGI [21] was used tbr elomng and expression. 
Restriction endonucleases, T4 ligas¢, T4 polynuclcotld¢ Rmase, helper 
phage MKI07, and pFlag-I vec:or were purchased from International 
Biotechnologies lne., New Haven, CT. Sequenase ver,o~on 2.0 was 
pttrchased from United States Biochcmlcals, Cleveland, OH, and 0:- 
[-'~S]th~o dATP 0,200 CVmmol) was from Dupont, Wilmington, DE. 
HS27 human skin fibroblast~ (ATCC catalog number CRL 1634) were 
the gift of M~chael Banda, University of Cahfornia t San Francisco 
2.2. Cotlstruction of e~:press:otl vector 
All DNA mampulations were performed as described [21] The 
following two primers w~th embedded Ht'ndlll recognition s~tes (un- 
derlined): 5'-CAAAGCTTGAGGCAGAAGGAGAAGCG-Y, and 
5'-CGAAGCTTTTCACGTGTGGAGGAGTC-3' were used to am- 
phfy a 4~4 bp fragment coding for the C-terminal region of rat ~M 
eDNA [20]. Amplification was performed by polymerase chain reac- 
tion (PCR) employing Taq polymerase and re,igcnt k~ts from Pcrkln- 
iElmcrlCetus, Emeryvdle, CA, in a Perkm.Elmer DNA thermal cycler. 
The amplified product was pnrified from a I% low gclhng temperature 
agarose gel {FMC B~oProducts, Rockland, ME), cut with Htndlll 
then ligated into the Hlndlll ~it¢ of pFlag-l. The heated product was 
used to transform E. cob TGI by the procedure of Hanahan [22]. The 
pla~m~d construct was characterized by endonuclease d~gestion and 
nucleotide sequence analysis [23]. To obtah, singlc-btranded DNA for 
sequencing, the tranffonnant ~va~ co-infected with helper phage 
MKI07 according to the supplier's instructions. 
2.~. S/te-dwected mutaget~esis 
Bases 105-188 of the vector (encoding the OmpA signal pepttde and 
the trypsmogen aetwauon pept~de) were deleted with the mutagenic 
primer: S'-GGGTGCTTC'. FCCTTCCATATGATATCTCCTG-Y. 
Mutal~enes~s was carried out as described [21] using ~ingle-ztrand 
template obtained with helper phage and Sequenase v rsion 20 as the 
extending polymera~e. Transl'ormants were sc.,'¢ened byPCR to detect 
the deletion, and one candidate0 termed p~x~M-RBD, was sequenced 
m it~ entirety to confirm the preem~on f the deletion. 
2.,~. Expressiat~ anti purification of ra¢ o~tM receptor binding clotnai~t 
(RBD) 
~. cob TGI tr.~nsformed with pa~M-RBD was grown in 2 1 of 2x 
TY containing 50/~g:ml ampicdim. When the A~ om of the culture 
rcaehcd 0.5 the cells were reduced with inopropyl thiogalactopyra- 
noside (IPTG) to a final concentration f I mM for3 h then harvostcd 
by cenmfttgahon at 13,000:,¢g for 30 rain The ¢¢11 pellet wa~ resus- 
pended m 300 ml ice-cold 50 mM Tns-CI buffer, pH 8.0, then ly~d 
by sonicatlon (Somcs and Matermls inc., Danbury, CT) for two 5 rain 
bursts The lysat¢ was centrifuged at 13,000xg for 40 rain and the 
supernatant wa~ loaded onto a 60 ml Q Sepharoee FF ion exchange 
column (Phannaem) equilibrated with 50 mM Tris-Cl, pH 8.0. The ml 
g~M-RBD was ¢luted with a linear gradient from n to 1 M NaCl in 
50 mM Trm.Ct, pH 8.0. Fractions were monitor'ed by SDS-PAGIE 
under educing condihons. 
Fractions containing the bulk of the rat (xt M-RBD were pooled and 
concentrated from 30 ml to 1.5 ml b2/ ultrafiitr'at~on (Amiens, 
Danver~, MA) with a 10 kDa cut-off membrane (YM 10). in addition, 
the buffer wa~ exchanged with Ix Hank's ~alt ~olution bnlTered with 
10 mM HEPES, pH 7.4 (binding buffer). The protein was further 
purdied on a 25 ml Superose 12 gel filtration column (Pharmaeia) 
equihbrated with the same buffer. The peak costuming a~M-RBD 
from the gel filtration column was u~-d directly for c¢11 binding stud- 
l eg .  
2.5 At)iron actct sequence and coenpo~'ttional analyM.~ 
Automated Edman degradation was carried out m an Applied Bio- 
systena~ 477A sequencer with on-line analysis ofphenyithtohydantoms 
umn8 an Applied Blosystems 120A HPLC Amino acid compositional 
analysis was carried oat laa  Beckman 6300 amino acid analyzer A 
sample of dehaltecl cztM*RBD was hydrolyex.~cl in 6 N HCI r : ,  24 h at 
110°C m vacuo. All residue weights were calculated by integration, 
with the exception of Pro and Trp. The weight of the protein sample, 
I% I allowmgcaleulatlon o ftheextinctloncoefficient (A~ ~),wasgalcalatcd 
as the attna of the weights of each residue. The extinction coeffielenl 
of the purified lecombinant protein wa~ i 1.5. 
2 6. Ma.~a zpectrotnetry 
A sample of purafied recombinant rat aiM-gi lD was analyzed b) 
Stanley Hefta, Beckman Research Institutg, Dearie, CA, using dee, 
trohprayqonizauon mas~ spectrometry [24]. Briefly, the sample wa~ 
introduced into a Finnegan TSQ-700 qnadropole mash spectromete~ 
by rever~e-phase liquid chromatography. The averaged multiple 
charged spectrum was collected over the scan range of 50-2000 AMU 
and the mass of the protein was assigned by using Fmnet~an-MA'l 
BIOMASS software. 
2.7. Cellular receptor binding assay 
The conformational change reduced by reaction of ~Ms with pro 
temases also occurs when many (zMs react with small primary amine: 
such as methylamme. Thus, methylamme-treated Msare often use, 
to imitate proteinasc inhibitor complexes for studying r¢,eeptor bind 
ins and ancillary events, obviating problems caused by mLroduein 
protcma.~e.s into cell binding experiments. Therefore, receptor-teen[ 
razed human o~.~M was made by incubation overnight in 0.2 M met! 
ylamme hydroehloride, pl-i 8.0, at a protein concentration f 4 mg/m 
Cell binding esl~riments were perlbrmcd esseatmll2,, as previousl 
described [18], except that human fibroblnsts were substituted R 
mouse macrophages. HS27 cells were seeded on 24-well culture plat( 
at a density of 20,000 celh per well m DMEM containing 10% fet~ 
bovine scram and grown lbr 48 h untd about 80% confluent. The o)1 
were washed twice with binding buffer at 4°C and meubat~! ,,vii 
various concentrations of unlabeled competing lig~md (methylamin, 
treated haman ~,M, or mt ~, M-RBD) containing 0.3 aM 'zi-).abek 
human cx,M-methylamlnc i  binding buffer with I% BSA. After 6 
at 4"C the cells were washed once with binding hufl'~r containing 1 
BSA, and twice with binding buffer alone. Cells were removed fro 
the wells following lysi~ in 0 5 ml 0.1 M NaOH and radioaetivi 
counted in a T-counter to deterrmne the extent of bound radioligan 
Non-specific bindhag was determined as the amount of radloligai 
bound )n Ihe pre~ence of 5 mM EDTA. All data points were measur~ 
at lea.~t three times and the result~ averaged. The !~ i~ the conccntr 
tins of hgand required to d~r~as¢ the specific binding of radiohgm 
by 50%. Under the conditions employed in this study, where t 
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radiohgand tracer xs used at its K~, the K. of competin8 liaands is 
calculated according to the relattonslup, l~0=2Kd, the use ol'which with 
this ~ystem was detaded m an earher pubhcatmn [18]. 
3. RESULTS AND DISCUSSION 
3.1. Construction o f  a rat ~M-RBD expression vector 
Our initial strategy was to drive expression of an 
OmpA signal peptide/trypsinogen activation peptide/ 
¢z~M-RBD fusion so that the protein would be secreted 
following OmpA removal to provide for facile purifica- 
tion using antisera raised against he activation peptide. 
Reeombinants were isolated and the correct orientation 
of the cqM-RBD insert was determined by restriction 
endonuclease digestion of plasmid minipreps and nude- 
otide sequencing. One recombinant was chosen for ex- 
pression by induction with IPTG as described in section 
2. This clone produced a product that was insoluble 
unless dissolved in 6 M guanidinium chloride, and 
which precipitated upon dialysis into 5 mM Tris-Cl 
buffer, pH 8, containing 0.05 mM EDTA. The product 
was sequenced and found to contain the GmpA signal 
peptide and the trypsinogen activation peptide, indicat.. 
ing lack of the expected signal peptide processing. We 
suspect hat the hydrophobicity of the OmpA signal 
peptide prevented proper folding, and promoted aggre- 
gation and precipitation of the recombinant rat a~M- 
RBD. Since expression was at such high levels, we de- 
cided to utilize the same expression vector, but to delete 
the OmpA signal peptide and the trypsinogen activation 
peptide from the recombinant vector and to express the 
protein devoid of the N-terminal extensions provided by 
the parent vector. 
Deletion was accomplished with a 31-mer mutagenic 
oligonucleotide primer complementary to sequences 
flanking the OmpA sit, hal peptide and the trypsinogen 
activation peptide, thus looping out 83 bp. PCR analy- 
sis of 24 colonies revealed 8 with deletions. One mutant 
was sequenced and was tbund to have the engineered 
deletion and no other mutations. This construct was 
designated p~xtM-RBD (Fig. 1). The initiatol' methion- 
ine provided by the vector i~ followed immediately by 
Gin ~3~ (numbering of Eggerston et al. [20]), which is the 
N-terminal residue of the C-terminal cz~M receptor 
binding domain [19]. 
3.2. Exp"es,:.ion and purification 
The 0qM.RBD expressed in E. coli was only visual- 
Jzed following induction with IPTG and was the second 
most abundant protein seen by Coomassie staining 
(Fig. 2). The protein migrated with an apparent size of 
22 kDa in reduced SDS-PAGE, rather than the 30 kDa 
size of the same fragment from a digest of natural rat 
~tM (see [I9]). When we attempted expression of a 
haman ct2M-RBD utilizing the same procedure, the 
product was insoluble whether or not it contained the 
Lag I rO~rOaSOr.,,. 
ran OronTotor r n Oron tor 
et IM goclll~ ¢egl,~n 
Tl tormtnator 
' ,~i~ tarmta~tor 
m¢~ soo  ! .~j 
\ 
pnB origin 
Fig. 1. Explesston w.'etor pct~M.Rl3D. The construct is derived from 
pFlag-1 with the gtM-RI3D codm~ region heated into the HmdIIl site 
of the m ultlple clomng region. The OmpA signal peptide and trypsm- 
ogen activation peptide of the parent vector were deleted by site- 
d~rected mutagenesis. Regions of the vector important in cloning and 
expression are indicated; further details of the vector may be obtained 
flora the distributors (~ec section 2). 
OmpA/trypsinogen activation peptide. Preliminary ex- 
periments confirmed that the rat atM-RBD was solu- 
ble, so we concentrated our efforts on purifying and 
characterizing this recombinant domain. Although the 
receptor binding fragment from the digest of natural rat 
a~M has previously been designated 20 kDa, its size is 
closer to 30 kDa in reduced SDS-PAGE, so we will refer 
to it as the 30 kDa fragment. The smaller size of the 
kDa 1 2 3 4 
97.4 ,,,---,_ 
66 .2  
45 
w 
21.5  " " ' - ' -  . . . . . . . .  
14.4 
Fig. 2. Purification of recombinant rat ct,M-RBD. All samples were 
boiled for 5 min in 1% SDS and 20 mM D13" and ran in a 5-15% linear 
gradient SDS-PAGE gel as deser i~t by [27]. Lane l, standard pro- 
tein~, lane 2, 40/~1 from 300 ml of crude lysate; lane 3, 10/./I from a 
30 ml pool of Q-Sepharose FF  eluate; lane 4, 2 ~l from 3 mI of 
Superose 12 peak. Singe lanes 2 and 4 show abotlt he same amount 
of rat ¢qM.RBD, we estimated thg yldd to b~ around 20%. 
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recombinant ~x=M-RBD is probably due to the lack of 
carbohydrate. 
During ion exchange on Q-Sepharose, the 0hM-RBD 
eluted in a sharp peak that was contaminated with a 50 
kDa protein in addition to various other high molecular 
weight proteins (Fig. 2, lane 3). These contaminants 
were removed by gel filtration on a Superose 12 column; 
the protein was over 90% pure as visually quantitated 
by Coomassie blue staining, with a yield of about 20%. 
The cz~M-RBD behaved as a single homogeneous spe- 
cies during both chromatography steps. The first 15 
residues of the purified ~x~M-RBD were confirmed by 
Edmaa degradation, and the mass of the protein was 
16,179 Da by mass ~peetrometry. This is in excellent 
agreeraent with the expected mass of 16,1~0 Da calcu- 
lated from the residue composition of the domain, and 
confirms the attthenticity of the product. 
3.3. Receptor bflzclhlg activity 
The 0qM-RBD competed with [l'~l]methylamine- 
treated human 0h_M for binding to fibroblasts, as has 
previously been shown for the natural 30 kDa fi'agment, 
implying recognition by the cz,~M receptor. The Kd of the 
recombinant 0ttM-RBD was 20 nM, lower than the 
value of 62 nM for the binding of natural 30 kDa frag- 
ment to mouse macrophages, (which was previously 
calctdated as 125 nM based on an assumed extinction 
coefficient of 0.5 [16,19]). This difference may reflect 
species differences of the receptor. 
There is approximately a two-order of magnitude dif- 
ference in binding ofa~M-RBD and natural 0~2M to the 
receptor (Fig. 3), This is consistent with previous results 
[19~25], and has two likely explanations; (i) 0~Ms (which 
are usually tetramers) bind by occupying two receptors, 
thus lowering the observed Ka [25] with respect o the 
monomeric RBD; (ii) not all of the receptor binding site 
i-,, contained in the RBD fragment [19]. We do not know 
which of these speculations i  correct, but the ability to 
expres, functional aM domains gives us the opportu- 
nity to test them. 
We conclude that the recombinant rat ~ttM-RBD and 
the 30 kDa fragment of natural rat g:M are close 
enough in their affinities that they can be thought of as 
equivalent in their ability to bind to the human receptor. 
Their similar affinities confirms earlier s-ggestiom [26] 
that carbohydrate is not important in binding of a- 
macroglobulins to their receptor. 
Although the rat a~M-RBD shares 60-75% identity 
with the equivalent regions of other ¢zMs, it lacks the 
two cyzteines present in the latter domains. Correct 
folding of the cysteine-eontaining RBDs probably re- 
quires disulfide formation, since we found that the re- 
combinant human ~z~M-RBD was insoluble, and since 
Sottrup-Jensen etal. [16] found that fragmentation, de- 
naturation or reduction of the natural human 0t_~M re- 
ceptor-binding fragment abolished its activity. Presum- 
ably, the rat 0qM-RBD is able to fold spontaneously 
100 
r= 
,so 
i 
- -  o ,40  
~j ~' o 
a3 • i 
0 t 1 10  100  1000 
unlal~oll,~gl t=gana {nM) 
Fig. 3 Binding of recombinant rat ¢xLM-RBD to human fibroblasts. 
The ability of recombinant rat %M-RBD (@) to prevent binding of 
t"'l-labeled h uman ~:M-mcthylamine ~s compared to that of unlabeled 
human a_~M-methylamine (O). Error bar~, are ~tandard eviations 
from the mean u~ing at least three data points per ligand concentra- 
tion. One hundred percent bmdmg was 771 epm above a background 
of 100 cpm 
without the formation of a disulfide, thus facilitating 
production of a soluble functional domain in E. coli. 
The ready solubility and high level of expression of the 
rat o~M-RBD makes it an excellent candidate for stud- 
ies, such as site-directed mutagenesis, designed to detail 
the mechanism and specificity by which the receptor 
recognizes ¢x-macroglobulins. 
Acknowh, dgmetlt.~: We thank Stanley Hefla for providinB the ma~s 
spectrometry data, Ida Thoger~n for eomposittolml aaal2¢~5, Oh,ar- 
leen Chu for providing purified ham:m ~x:M, Alex Rinehart for cultur- 
ing the IIS27 eelh, and Dudly $triekland for helpful dl~ctmions. Thin 
work was supported by NIH Grants GM 38800 and HL 24066. 
REFERENCES 
[I] Starkey, P.M. and Barrett, A.J. (1977) in: Proteinase~ in Mam- 
malian Cells and Tissues (A.J. Barrett ed/) pp. 663-696, Elsevier, 
Amsterdam, 
12] Fames, C.F. and Atkin~on, J P (1991} Immunol Today 12. 
295-300 
[31 Soarup-Jensen, L. (1987) ill Plasma Proteins (F.W. Putnam ¢d 
pp 191-291, Academic Press. 
[4] Mllller-Eberhard, H,L (1938) Annu. Rev Bioehem. 57, 321-347. 
[5] PiLzo, S V. (198h) B~oeherntstry 1,242-246. 
[6] James, K. (1990) Immunol Today 11. 163-169. 
[7] Munek Petersen. C,and Moestrup, S.K. (1990t immunol Today 
11,430-,43 I.
18] Chu, C.T. and lh~'2o, S V (1991) Immunol. Today 12, 249. 
[9] Strickland, D.K., A~hcom, J.D, Wiiham~, S., Burgess, W.H., 
Mighormi, M. and Argraves, W S. (1990)J. Biol. Chem. 265, 
17,;01-i7404. 
[10] Kristen~a, T,  Moestrup, S.J., Gheman, J., llent~n, L., $~and, 
O. and Sottrup-Jensen, L. (1990) FEBS Left. 276, 151-1~55. 
[11] Her,', J., Hamann, U., Rogue, S., Myklebo~t, O., Gausepohl, H. 
and Starkey, K.K. (1988) EMBO J. 7, 4119-4127. 
[12] Van Dtlk, M.C M,  Ziere, G J., Boers, W., Linthom, C., Blister- 
bosch, M.K. and van Berkel, T.LC. (1991) Biochem. J. 279, 
863-870 
[13] Kounna,h M Z., Morris, R.E., Thompson, M.R., Fitzgerald, 
D.J., Striekland, D.K. and Sahnger, C.B. (I992) J. Biol. Chem. 
268, 12420-12423. 
201 
Volume 313, number 2 FEBS LETTERS November 1992 
[I,~] Bu, G., Williams+ S., Strlclda~td, D K. and Schwartz, A.L. (t992) 
Proc. Natl. Acad. $¢i. USA 89, 7427-'/431. 
[taI Orth, K,, Madison+ E,L., G~thing, M ..t, Sltmbrook, J,F. and 
H~rz, J, (1992) Proc. Natl. Acad. Sci USA 89, 7422-7426. 
[161 .%ttrup-len~n, L., Oli~mtm, J. and van Leaven, F, (1986) FEB$ 
Lc/t. 20~, 20-24, 
[171 Van L¢uven, F,~ Merynen, P,, Cassiz~an, J J. and "Can don 
Bcrghe, H. 0986) J. Biol. Chem, 261, 6933-6937. 
[IB] Roche., P.A., Strickland, D,K,, EaBbild, 13. aria Piz2o, S.V. 
(1888) J. Biol. Chem. 263, 67t'~-6721. 
[l 9] EnghlM, J,d., Tho&ersen, I.O., Roche, P.A, and Pgz.o, S,V, (t989) 
Bmch~rntstry 28, ld0f;--1412. 
[20] Eggertsen, G, Hudson, O,, Shietd~, B., R¢~.~i, D. and Fcy, G.H. 
(i99~) Mof. Blol Mcd. 8, 287-302. 
[21] ,~amhrook, .L, Fntch, E.F, and Maniats, T, 09~.9) Molecular 
Clonin/~: A Laboratory Manual, Cold Spring Harbor Laboratory 
Press, Cold Spnng l-larbc~r, W'r'. 
[~2] Hahn'nan, D, {19~3)J. MoL Biol. tti6, 5S705~0. 
[23] Sauger, F,  Nieklen, S. and Co~1~¢., A.R, ([877) Proc. Nail, 
A~a6. S~. USA ?g, 5463-5476, 
[24~ Xm, Q.-W,, Cho, H.L~ Calay~a~/, J., Mumford, R.A,, Swiderek, 
K.M., Le~, T.D., Dine, A,, Tro~o, T. and Na~.haa, C (|992) 
Sv~¢ace 256, 225-22~. 
[25] Moestrup, S.K. and Oligalann, J. (1991) J. Biol. Chem. 256, 
14011-14017. 
[26] lmtmv, M J. and Pizzo~ S.'V. (]98 I)L Blol, Chore. 2~6, BI M--~ 139. 
[27] Bury, A. (198t) J. Chro~n~ttogr. 213, 491-500. 
202 
